These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 9857925)

  • 1. Safety and utility of atropine addition during dobutamine stress echocardiography for the assessment of viable myocardium in patients with severe left ventricular dysfunction.
    Poldermans D; Rambaldi R; Bax JJ; Cornel JH; Thomson IR; Valkema R; Boersma E; Fioretti PM; Breburda CS; Roelandt JR
    Eur Heart J; 1998 Nov; 19(11):1712-8. PubMed ID: 9857925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction.
    Williams MJ; Odabashian J; Lauer MS; Thomas JD; Marwick TH
    J Am Coll Cardiol; 1996 Jan; 27(1):132-9. PubMed ID: 8522686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of myocardial viability in medically treated patients with global left ventricular dysfunction early after an acute uncomplicated myocardial infarction: a dobutamine stress echocardiographic study.
    Picano E; Sicari R; Landi P; Cortigiani L; Bigi R; Coletta C; Galati A; Heyman J; Mattioli R; Previtali M; Mathias W; Dodi C; Minardi G; Lowenstein J; Seveso G; Pingitore A; Salustri A; Raciti M
    Circulation; 1998 Sep; 98(11):1078-84. PubMed ID: 9736594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dobutamine-atropine stress echocardiography for risk stratification in patients with chronic left ventricular dysfunction.
    Smart SC; Dionisopoulos PN; Knickelbine TA; Schuchard T; Sagar KB
    J Am Coll Cardiol; 1999 Feb; 33(2):512-21. PubMed ID: 9973033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and feasibility of dobutamine-atropine stress echocardiography in patients with ischemic left ventricular dysfunction.
    Cornel JH; Balk AH; Boersma E; Maat AP; Elhendy A; Arnese M; Salustri A; Roelandt JR; Fioretti PM
    J Am Soc Echocardiogr; 1996; 9(1):27-32. PubMed ID: 8679234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of myocardial viability recognized by low-dose dobutamine echocardiography in chronic ischemic left ventricular dysfunction.
    Sicari R; Picano E; Cortigiani L; Borges AC; Varga A; Palagi C; Bigi R; Rossini R; Pasanisi E;
    Am J Cardiol; 2003 Dec; 92(11):1263-6. PubMed ID: 14636900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of antianginal therapy with a calcium antagonist and nitrates on dobutamine-atropine stress echocardiography. Comparison with exercise electrocardiography.
    Dodi C; Pingitore A; Sicari R; Bruno G; Cordovil A; Picano E
    Eur Heart J; 1997 Feb; 18(2):242-7. PubMed ID: 9043840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and feasibility of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in diabetic patients unable to perform an exercise stress test.
    Elhendy A; van Domburg RT; Poldermans D; Bax JJ; Nierop PR; Geleijnse ML; Roelandt JR
    Diabetes Care; 1998 Nov; 21(11):1797-802. PubMed ID: 9802723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between dobutamine response of dyssynergic myocardium and angiographically documented blood supply.
    Klaar U; Berger R; Gwechenberger M; Wutte M; Porenta G; Sochor H; Maurer G; Baumgartner H
    J Am Soc Echocardiogr; 2003 Sep; 16(9):949-57. PubMed ID: 12931107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization?
    Schinkel AF; Poldermans D; Rizzello V; Vanoverschelde JL; Elhendy A; Boersma E; Roelandt JR; Bax JJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):385-90. PubMed ID: 14762345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and prognostic value of dobutamine-atropine stress echocardiography early in unstable angina.
    Sitges M; Paré C; Azqueta M; Bosch X; Miranda-Guardiola F; Velamazán M; Magriñá J; Sanz G
    Eur Heart J; 2000 Jul; 21(13):1063-71. PubMed ID: 10843824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of glucose-insulin-potassium infusion on chronic ischaemic left ventricular dysfunction.
    Khoury VK; Haluska B; Prins J; Marwick TH
    Heart; 2003 Jan; 89(1):61-5. PubMed ID: 12482794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypotensive response during dobutamine stress echocardiography in coronary patients: a common event of well-functioning left ventricle.
    Rallidis LS; Moyssakis IE; Nihoyannopoulos P
    Clin Cardiol; 1998 Oct; 21(10):747-52. PubMed ID: 9789696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do the presence and amount of dysfunctional but viable myocardium affect the perioperative outcome of coronary artery bypass graft surgery?
    Meluzín J; Cerný J; Nemec P; Frélich M; Stetka F; Spinarová L
    Int J Cardiol; 1999 Dec; 71(3):265-72. PubMed ID: 10636534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stress echocardiography using adenosine combined with nitroglycerin-dobutamine in the detection of viable myocardium in patients with previous myocardial infarction.
    Kranidis A; Bouki T; Kostopoulos K; Anthopoulos P; Kappos K; Antonellis J; Bonou M; Sideris A; Ralli D; Tavernarakis A; Kesse M; Anthopoulos L
    Angiology; 1997 Feb; 48(2):127-33. PubMed ID: 9040267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low dose dobutamine echocardiography predicts improvement in functional capacity after exercise training in patients with ischemic cardiomyopathy: prognostic implication.
    Belardinelli R; Georgiou D; Purcaro A
    J Am Coll Cardiol; 1998 Apr; 31(5):1027-34. PubMed ID: 9562003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of beta-blockade and atropine on ischemic responses in left ventricular regions subtending coronary stenosis during dobutamine stress echocardiography.
    Chen L; Ma L; de Prada VA; Chen M; Feng YJ; Waters D; Gillam L; Chen C
    J Am Coll Cardiol; 1996 Dec; 28(7):1866-76. PubMed ID: 8962578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of global left ventricular function after bypass surgery in patients with severe left ventricular dysfunction. Impact of pre-operative myocardial function, perfusion, and metabolism.
    Pasquet A; Lauer MS; Williams MJ; Secknus MA; Lytle B; Marwick TH
    Eur Heart J; 2000 Jan; 21(2):125-36. PubMed ID: 10637086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. Investigators of this Multicenter Study.
    Meluzín J; Cerný J; Frélich M; Stetka F; Spinarová L; Popelová J; Stípal R
    J Am Coll Cardiol; 1998 Oct; 32(4):912-20. PubMed ID: 9768711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dose wall motion score predicts the short and long-term benefit of surgical revascularization in patients with ischemic left ventricular dysfunction.
    Abdul Ghaffar Y; Maskoun W; Mustafa NG; Feigenbaum H; Sawada SG
    Int J Cardiovasc Imaging; 2019 Sep; 35(9):1651-1659. PubMed ID: 31053980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.